BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Sodium Oxybate readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Sodium Oxybate\, from ClinicalTrials.gov 
 estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06809803-9515@assetmemo.bio
DTSTAMP:20261121T005448Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:Sodium Oxybate: Phase 2 readout est. (NCT06809803)
DESCRIPTION:Sodium Oxybate\, phase 2\, Narcolepsy.\nStudy: Extended-release
  Sodium Oxybate in Children\nEstimated primary completion: June 2027. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/sodium-oxybate#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT06809803
URL:https://assetmemo.bio/drug/sodium-oxybate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07041203-9515@assetmemo.bio
DTSTAMP:20261121T005448Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:Sodium Oxybate: Phase 1 readout est. (NCT07041203)
DESCRIPTION:Sodium Oxybate\, phase 1.\nStudy: Extended-release Sodium Oxyba
 te (Lumryz) in Spasmodic Dysphonia and Voice Tremor\nEstimated primary com
 pletion: 30 September 2027. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/sodium-oxybate#upcoming-events\nRegistry record: https://clinicaltr
 ials.gov/study/NCT07041203
URL:https://assetmemo.bio/drug/sodium-oxybate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07596342-9515@assetmemo.bio
DTSTAMP:20261121T005448Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:Sodium Oxybate: Phase 2 readout est. (NCT07596342)
DESCRIPTION:Sodium Oxybate\, phase 2.\nStudy: Electrophysiological Analysis
  of Gamma-Hydroxybutyrate-induced Sleep in Intensive Care Patients\nEstima
 ted primary completion: October 2027. This is a ClinicalTrials.gov estimat
 e\, not a confirmed readout date\, and it can move.\nDrug page: https://as
 setmemo.bio/drug/sodium-oxybate#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT07596342
URL:https://assetmemo.bio/drug/sodium-oxybate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07794982-9515@assetmemo.bio
DTSTAMP:20261121T005448Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Sodium Oxybate: Phase na readout est. (NCT07794982)
DESCRIPTION:Sodium Oxybate\, phase na.\nStudy: Sodium Oxybate for Postopera
 tive Sleep Disturbance After Thoracic Surgery\nEstimated primary completio
 n: December 2027. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/sod
 ium-oxybate#upcoming-events\nRegistry record: https://clinicaltrials.gov/s
 tudy/NCT07794982
URL:https://assetmemo.bio/drug/sodium-oxybate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
